aTYR Pharma director Paul Schimmel buys $184k in firm shares By Investing.com
In a current sequence of transactions, Paul Schimmel, a director at aTYR…
Purdue Pharma seeks litigation ceasefire after SCOTUS ruling By Reuters
By Dietrich Knauth NEW YORK (Reuters) - Purdue Pharma on Tuesday requested…
